BECOME MEMBER SUPPORT
Year Cancer type Speaker
Webinar - Lung Cancer Treatment Updates On 14 Oct 2022
Welcome & Introduction
Role of Alecensa in 1L ALK+ NSCLC patients Beyond The Barriers
Real World Evidence Osimertinib as SoC in the management of EGFRm NSCLC